Dr. Corwin Martin, M.D., D.D.S.

EDUCATION:

University of Texas at Southwestern Medical Center, Southwestern Medical School
Dallas, Texas
Conferred the degree of Doctor of Medicine
July 1, 1995 – June 1998

Baylor College of Dentistry
Dallas, Texas
Conferred the degree of doctor of Dental Surgery
August 1, 1991 – June 1995

University of Texas at Austin
Austin, Texas
Biology-major, Chemistry-minor
Conferred the degree of Bachelor of Arts
August 1, 1986 – December 1990

INTERNSHIP:

Acting Internship in General Surgery
Department of Surgery
Division of Oral and Maxillofacial Surgery
University of Texas at Southwestern Medical Center,
Parkland Health and Hospital System
Affiliated Hospitals:
Children’s Medical Center of Dallas
Zale-Lipshy University Hospital
Dallas Veteran’s Medical Center
St. Paul Medical Center
July 1, 1998 – June 30, 1999

EXPERIENCE:

Research Specialists of Arizona
Phoenix, AZ USA 85018
April 2016 – Present

Estetica – Cosmetic & Reconstructive Surgery of Scottsdale.
9450 East Ironwood Square Drive
Scottsdale, Arizona 85258
July 30, 2004 – Present

Scottsdale Oral and Maxillofacial Surgery
3501 North Scottsdale Road, Suite #110
Scottsdale, Arizona USA 85251
November 1, 2002 – July 30, 2004

FELLOWSHIP/SPECIALTY TRAINING:

Facial Aesthetic and Reconstructive Surgery
Department of Surgery
Division of Oral and Maxillofacial Surgery
University of Texas at Southwestern Medical Center
Stephen W. Watson, M.D., D.D.S.
July 1, 2001 – April 30, 2002

Oral and Maxillofacial Surgery
Department of Surgery
Division of Oral and Maxillofacial Surgery
University of Texas at Southwestern Medical Center,
Parkland Health and Hospital System
Affiliated Hospitals:
Children’s Medical Center of Dallas
Zale-Lipshy University Hospital
John Peter Smith Hospital of Fort Worth
Dallas Veteran’s Medical Center
St. Paul Medical Center
July 1, 1999 – June 30, 2001

MEDICAL LICENSES AND CERTIFICATIONS:

Board Certification
Diplomate
American Board of Cosmetic Surgery
August 2010

Diplomate
American Board of Oral and Maxillofacial Surgery
February 2006

Facility Certification
The Joint Commission
Office Based Surgical Facility
Estetica – Cosmetic and Reconstructive Surgery
Accredited, January 2008
Status – Current

Licensure:
Dental License: State of Texas, USA
License Number: 26094
Conferred: October 27, 2010
Status: Current

Dental License: State of Arizona, USA
License Number: 5182
Conferred: April 3, 2000
Status: Current

Medical License: State of Texas, USA
License Number: L0398
Conferred: August 26, 2000
Status: Current

Medical License: State of Arizona, USA
License Number: 29085
Conferred: March 2, 2001
Status: Current

NIDA Clinical Trials Network / GCP
2016 – 2026

PROFESSIONAL AFFILIATIONS:

American Academy of Cosmetic Surgery
American Society of Lipo-Suction Surgery
American Association of Oral and Maxillofacial Surgeons
American College of Oral and Maxillofacial Surgeons
American Dental Association
American Medical Association
American Society of Cosmetic Breast Surgery
Arizona Society of Cosmetic Surgery
Arizona Society of Oral and Maxillofacial Surgeons
Arizona Dental Association
Omicron Kappa Upsilon Fraternity
Phoenix Society of Oral and Maxillofacial Surgeons

HOSPITAL AFFILIATIONS:

Scottsdale Healthcare, Shea Campus, Scottsdale, Arizona
Scottsdale Healthcare, Thompson Peak Campus, Scottsdale, AZ
Muenster Memorial Hospital, Muenster, Texas

RESEARCH EXPERIENCE:

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of ***********(** ug or *** ug) Administered Orally for 12 Weeks to Patients with Chronic Idiopathic Constipation.

A Multicenter Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of ******* Topical Gel, 0.1%, to ****** Gel Comparator in the Management of Painful Diabetic Neuropathy.

A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy, Tolerability and Safety of ****** Prolonged-release in Patients with Moderate to Severe Chronic Low Back Pain.

A Randomized, Double-blind, Placebo-controlled, Multicenter Long-term Safety and Tolerability Study of ***** in Patients with Hyperlipidemia at High Cardiovascular Risk Who are not adequately Controlled by Their Lipid-Modifying Therapy.

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of ***** Relative to ***** and ***** on COPD Exacerbations over a 52-Week Treatment Period in Subjects with Moderate to Very Severe COPD.

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic- Dosing, Multi-Center Study to Assess the Efficacy and Safety of ****, ****, and **** Compared with ********* as an Active Control in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease.

A Randomized, Double-Blind, Parallel-Group, 52-Week, Chronic-Dosing, Multi-Center Study to Assess the Safety and Tolerability of ****, **** and ***** in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease.

A Phase 3, 12-week, Randomized, Double−Blind Placebo−Controlled Parallel Group Study of ******* **** in Subjects with Chronic Obstructive Pulmonary Disease.

A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bio

Immediate Access

• Bone densitomety: Hologic Densitometer
• Radiology: CT, MRI, Nuclear Medicine, General Radiology
• EMG / NCV: Cabwell 62000A
• SPECT: One and two head start scanner
• Outpatient surgical suite with endoscopy and biopsy capability
• Sleep Laboratory, Ophthalmology

Equipment

• High capacity digital copier
• -20 EF monitored freezer
• Centrifuge
• ECG Machine
• Dedicated Fax
• Scanner capabilities
• Refrigerated drug storage